Literature DB >> 29465427

Dihydrotestosterone and cancer risk.

Yi X Chan1,2, Bu B Yeap1,2.   

Abstract

PURPOSE OF REVIEW: Androgens have been implicated in prostate growth; however, the role of androgens in prostate cancer development is not clear. Furthermore, studies suggest a role for androgens in female-hormone-dependent cancers and common nonhormone dependent cancers. This study aims to review key studies and more recent studies of dihydrotestosterone (DHT) and cancer risk. RECENT
FINDINGS: Epidemiological studies are reassuring as they have not associated endogenous androgens with prostate cancer risk. Intraprostatic regulation of DHT is becoming recognized as an important area of research to clarify the role of DHT in prostate cancer development. In females, further understanding of intracrine regulation of sex hormones and interactions between androgens and estrogens in influencing breast and endometrial cancer risk are required. Studies show a signal for DHT in modulating lung and colorectal cancer growth; however, research in this area is relatively scarce and further studies are required to clarify these associations.
SUMMARY: Although concerns of prostate cancer risk remain, there is also potential for androgens to modulate the growth and development of other common cancers. Further research is required as this may have clinical implications.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29465427     DOI: 10.1097/MED.0000000000000411

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  4 in total

1.  Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma.

Authors:  Junjie Hu; Huansha Yu; Liangdong Sun; Yilv Yan; Lele Zhang; Gening Jiang; Peng Zhang
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

2.  HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma.

Authors:  Tian Tian; Fu Hong; Zhiwen Wang; Jiaru Hu; Ni Chen; Lei Lv; Qiyi Yi
Journal:  Cell Death Discov       Date:  2021-11-08

3.  Comparative Proteomic Analysis of Liver Tissues and Serum in db/db Mice.

Authors:  Yu Zhang; Xiumei Wu; Mengyun Xu; Tong Yue; Ping Ling; Tingyu Fang; Sihui Luo; Suowen Xu; Jianping Weng
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

4.  Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma.

Authors:  Lei Lv; Yujia Zhao; Qinqin Wei; Ye Zhao; Qiyi Yi
Journal:  Cancer Cell Int       Date:  2020-06-03       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.